Open access peer-reviewed chapter

Polycystic Ovary Syndrome: It’s Not Just Infertility

Written By

Naheed Akhter, Sadia Sana, Naila Iftikhar, Muhammad Adnan Ahsan, Abu Huraira and Zafaar Siddique

Submitted: 15 November 2021 Reviewed: 07 December 2021 Published: 21 March 2022

DOI: 10.5772/intechopen.101923

From the Edited Volume

Polycystic Ovary Syndrome - Functional Investigation and Clinical Application

Edited by Zhengchao Wang

Chapter metrics overview

151 Chapter Downloads

View Full Metrics


Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine issue described by unpredictable menses, hyperandrogenism, and polycystic ovaries (PCO). The commonness of PCOS changes relying upon which measures are utilized to conclude yet is just about as high as 15–20% when the European culture for human propagation and embryology/American culture for regenerative medication rules are utilized. Clinical signs incorporated grown-ups incorporate sort 1 diabetes, type 2 diabetes, and gestational diabetes. Insulin opposition influences half 70% of ladies with PCOS prompting a few comorbidities including metabolic condition, hypertension, dyslipidemia, glucose narrow-mindedness, and diabetes. Studies show that ladies with PCOS are bound to have expanded coronary corridor calcium scores and expanded carotid intima-media thickness. Psychological wellness problems including despondency, uneasiness, bipolar turmoil, and voraciously consuming food issues additionally happen all the more habitually in ladies with PCOS. Weight reduction works on feminine abnormalities, indications of androgen abundance, and barrenness the board of clinical appearances of PCOS incorporates oral contraceptives for feminine inconsistencies and hirsutism. Spironolactone and finasteride are utilized to treat indications of androgen overabundance.


  • infertility
  • PCOS
  • subfertility
  • endometrial malignancy
  • hirsutism

1. Introduction

In 1935, scientists depicted a few ladies giving oligo/amenorrhea joined with the presence of reciprocal polycystic ovaries (PCO) set up during the medical procedure. Three of these seven ladies likewise gave weight, while five gave indications of hirsutism [1, 2, 3, 4, 5]. Just a single lady was both fat and showed hirsutism [6]. These discoveries infer that on the off chance that PCO is determined by morphology in ladies to have oligo/anovulation, not every one of the elements which are accepted to be related to PCOS should be present [5, 7]. Moreover, with the utilization of transvaginal ultrasonography, it has become obvious that ladies with oligo/amenorrhea, weight, and hirsutism do not all have the common PCO morphology. The event of significant heterogeneity in clinical indications and endocrine provisions related to polycystic ovary disorder (PCOS) infers that a few ladies with PCO on ultrasound output might even show none of the different elements of PCOS.

Since there is at present no general meaning of PCOS, distinctive master bunches utilize various measures to analyze the condition. In any case, every one of the gatherings searches for the accompanying three components [8, 9].

  1. Feminine abnormalities, such as light periods or skipped periods, that outcome from long haul nonappearance of ovulation (the interaction that sets a full-grown egg-free from the ovary).

  2. Undeniable degrees of androgens that do not result from different causes or conditions, or indications of high androgens, such as overabundance body or beard growth.

  3. Numerous pimples of a particular size on either of the ovaries as identified by ultrasound.


2. Causes of polycystic ovary syndrome

Doctors do not know what causes PCOS. They admit that a high amount of male hormones prevent the ovaries from producing hormones and eggs normally. Genes, insulin resistance, and inflammation have all been associated with excess androgen production [10].

2.1 Genes

Research shows that polycystic ovary syndrome runs in families.

Almost certainly, numerous qualities—not only one—add to the conditions [11].

2.2 Insulin resistance

More than 70% of ladies with polycystic ovary syndrome have insulin opposition, implying that their body cells cannot utilize insulin appropriately. The chemical produces by the pancreas to help the body use sugar from food sources for energy is insulin [12].

At the point when cells cannot utilize insulin appropriately, the interest of the body in insulin increments. The pancreas produces more insulin to redress. Additional insulin activates the ovaries to create more androgen.

The significant reason for insulin obstruction is weight. Corpulence and insulin opposition can expand your danger for type 2 diabetes [13].

2.3 Inflammation

Ladies with polycystic ovary syndrome frequently have expanded degrees of irritation in their bodies. Being overweight can in like manner add to aggravations. Research has connected overabundance irritation to higher androgen levels [14].


3. PCOS dangers

If you have been determined to have polycystic ovary disorder (PCOS), comprehend the drawn-out well-being hazards related to the sickness, which include the following:

  1. Fruitlessness or subfertility

  2. Endometrial malignant growth

  3. Diabetes

  4. Lipid anomalies

  5. Cardiovascular dangers

  6. Obstructive rest apnea

Not all ladies with PCOS will foster these conditions, however, having PCOS expands your danger. Accordingly, have your well-being checked routinely by a doctor who has experience treating ladies with PCOS. Normal doctor visits ought to be booked through your conceptive years and proceed after menopause, even though you will presently do not have sporadic periods and other PCOS manifestations might diminish after the feminine cycle closes [8, 10].

The globally regarded doctors at the middle for polycystic ovary condition supervise the consideration of thousands of ladies with PCOS consistently. UChicago medication is additionally home to specialists in malignancy, coronary illness, and other medical issues who can analyze and treat these conditions if they create [3].

3.1 Fruitlessness or subfertility

Numerous ladies do not understand that they have PCOS until they see a specialist decide why they cannot get pregnant. Fruitlessness or subfertility (diminished richness) is a typical issue for ladies with PCOS.

This might be because of the lopsidedness of chemicals brought about by an overproduction of the male chemical testosterone. The ovaries may inconsistently deliver ova (eggs). Because of the accessibility of ovulation-inciting medications and advances in helped conceptive advances, numerous ladies with PCOS would now be able to imagine [15].

Even though PCOS might diminish a lady’s opportunities to become pregnant, the illness is certifiably not a substitute for anti-conception medication. Numerous ladies with PCOS do become pregnant, without clinical help. Ladies who are physically dynamic and do not wish to imagine ought to think about utilizing a prophylactic [16].

3.2 Endometrial malignancy (endometrial carcinoma)

Ladies with PCOS have all the earmarks of being at expanded danger for creating malignant growth of the endometrium (coating of the uterus) further down the road. From your teenagers through menopause, all ladies experience a month-to-month development of the endometrial covering in the uterus, as the body sets itself up for the capability of a treated egg. On the off chance that you do not become pregnant, the coating regularly is shed through the period [17].

Ladies with PCOS likewise experience the month-to-month development of the endometrial covering. Notwithstanding, the covering is not adequately shed since she has rare or nonexistent feminine periods. In this way, the covering proceeds to assemble and can build the danger of endometrial malignant growth [18].

3.3 Diabetes

Insulin assists the body with using or interaction (glucose). Insulin obstruction or weakened glucose resistance have been connected to PCOS. Moreover, significant degrees of insulin invigorate the creation of testosterone, which bothers PCOS [17, 19].

By age 40, up to 40% of ladies with PCOS have some degree of unusual glucose resilience, as one or other diabetes or weakened glucose resistance. Our doctors at UChicago Medication’s Middle for Polycystic Ovary Disorder direct continuous exploration on the job of insulin opposition and insulin activity in ladies with PCOS. A lot of this exploration has been distributed in clinical diaries, such as New Britain Diary of Medication and Diary of Clinical Endocrinology and Digestion [20].

3.4 Lipid irregularities

Hyperandrogenism (expanded testosterone) can prompt a troublesome lipid profile in ladies with PCOS. This implies that a lady with PCOS might have an undeniable degree of fat substances in her circulatory system. In certain ladies, the blood lipid profile might show a lower pace of high-thickness lipoproteins (HDL the “Great” cholesterol) and a higher pace of low-thickness lipoproteins (LDL the “Awful” cholesterol). This irregularity builds the danger of cardiovascular sickness [21].

3.5 Cardiovascular dangers

Proof proposes that ladies with PCOS are at expanded danger for coronary illness and other cardiovascular sicknesses. Moreover, the inclination for ladies with PCOS to be overweight expands the danger of cardiovascular sickness, similarly as heftiness increments cardiovascular danger among ladies and men who do not have PCOS [20].

3.6 Obstructive rest apnea

Studies led at the College of Chicago have affirmed the outstandingly high danger of obstructive rest apnea among ladies with PCOS. While expanded body weight adds to this danger, ladies with PCOS appear to be at high danger as an outcome of different elements notwithstanding weight. For instance, the high testosterone levels in PCOS additionally appear to assume a part in the improvement of rest apnea [22].


4. Sign and symptoms

Polycystic ovary condition (PCOS) is a hormonal issue normal among ladies of conceptive age. PCOS indications might start soon after pubescence, yet can likewise create during the later high scholar years and early adulthood. Since indications might be ascribed to different causes or go unrecognized, PCOS might go undiscovered for quite a while. Generally, an analysis of PCOS can be made when you experience two of these three signs [23].

4.1 Unpredictable periods

Individuals with PCOS regularly have sporadic or missed periods because of not ovulating. Rare periods are a typical indication of PCOS. For instance, you may have less than nine periods every year with over 35 days between periods. Different ladies experience the ill effects of strangely weighty periods [24].

4.2 Polycystic ovaries

Albeit certain individuals might foster blisters on their ovaries, many individuals do not. Your ovaries may be developed and contain follicles that encompass the eggs. Accordingly, the ovaries may neglect to work routinely [18, 25].

4.3 Overabundance androgen

Raised degrees of male chemicals might bring about actual signs, such as overabundance of facial and body hair (hirsutism), and sometimes extreme skin inflammation and male-design hairlessness [25, 26].


5. Symptoms

  • Default period, sporadic period, or extremely light period

  • Ovaries that are prodigious or have many sores

  • Overabundance body hair, including the chest, stomach, and back (hirsutism)

  • Increase in weight, particularly around the tummy (mid-region)

  • Acne or sleek epidermis

  • Male-design hairlessness and diminishing hairs

  • Infertility

  • Little pieces of abundance skin on neck and armpits (skin labels)

  • Dull or toughness small areas on the rear of the neck and armpits [27].


6. Indications of polycystic ovary syndrome

6.1 Weight gain

About a portion of individuals with polycystic ovary syndrome will have weight gain and stoutness that is hard to oversee [28].

6.2 Exhaustion

Many individuals with polycystic ovary syndrome report expanded exhaustion and low energy. Related issues, for example, helpless rest might add to the sensation of weariness [29].

6.3 Undesirable hair development (hirsutism)

Regions influenced by overabundance hair development might incorporate the face, arms, back, chest, thumbs, toes, and mid-region. Hirsutism identified with PCOS is because of hormonal changes in androgens [30].

6.4 Diminishing hair on the head

Going bald identified with polycystic ovary syndrome might increment in middle age.

6.5 Fruitlessness

PCOS is the main source of female fruitlessness. Notwithstanding, only one out of every odd lady with PCOS is something very similar. Albeit certain individuals might require the help of fruitfulness medicines, others can imagine normally [31].

6.6 Skin inflammation

Hormonal changes identified with androgens can prompt skin inflammation issues. Male chemicals can make the skin oilier than expected and cause breakouts in regions, such as the face, chest, and upper back [31].

6.7 Obscuring of skin

You might see thick, dull, smooth patches of skin under your arms or bosoms, or on the rear of your neck [32].

6.8 State of mind change

Having polycystic ovary syndrome can improve the chances of emotional episodes, sorrow, and uneasiness [11, 33].

6.9 Pelvic agony

Pelvic agony might happen with periods, alongside weighty dying. It might likewise happen when a lady is not dying [11, 32].


7. How PCOS affects fertility

Polycystic ovarian disorder is the main source of ovulatory fruitlessness. Up to 80% of females who have polycystic ovary syndrome experience related fruitfulness challenges. In case you are experiencing issues getting pregnant, you have an assortment of treatment choices. A certain way of life alterations is the best option to further develop fruitfulness, trailed by prescriptions, hormonal medicines, and helped regenerative strategies [34].

A trademark indication of polycystic ovary syndrome is sporadic or missing feminine periods. Certain individuals with PCOS may not get a period for months, even a long time, while others will encounter draining for quite some time. A little level of those with polycystic ovary syndrome will encounter month-to-month cycles [35].

Sporadic or missing feminine cycles in polycystic ovary syndrome are because of a fundamental hormonal awkwardness [36].

  • Normally, sex chemicals, such as luteinizing hormones (LH), are emitted at a consistent heartbeat rate. In polycystic ovary syndrome, LH is emitted at a fast heartbeat rate.

  • The LH emission design conveys messages to the ovaries to siphon out more elevated levels of male chemicals, like testosterone.

  • Overabundance LH and testosterone trigger negative input circles, which adjust the arrival of chemicals/hormones that control ovulation and the feminine cycle.

  • The follicle that would regularly be delivered to be prepared in pregnancy never completely develops and in some cases, does not get set free from the ovary.

Minuscule follicles show up as a string of pearl on an ultrasound, sometimes encompassing the ovary. These follicles are called cysts/pimples because of their appearance, despite the fact that they vary from the ovarian sores that can develop and crack. Unsuccessful labors are likewise normal with polycystic ovary syndrome and might be because of the imbalance of sex chemicals and more elevated levels of insulin [35, 37].


8. Diagnoses

Medical care suppliers search for three trademark elements of polycystic ovary disorder (PCOS)—nonattendance of ovulation, significant degrees of androgens, and blisters on the ovaries. Having at least one of these components could prompt a finding of PCOS. If your clinical history proposes that you may have PCOS, your medical care supplier will preclude different conditions that might cause comparable manifestations [37, 38].

8.1 Before making a finding of PCOS

8.1.1 Take a full family history

Your medical care supplier will get some information about your feminine cycle and any set of experiences of fruitlessness. The person likewise will find out if you have a mother or sister with PCOS or with manifestations like yours, as PCOS will in general spat families [39].

8.1.2 Conduct a complete physical exam

Your medical care supplier will do an actual test and search for additional hair development, skin break out, and different indications of undeniable levels of the chemical androgen. The individual additionally will take your pulse, measure your abdomen, and work out your weight list, a proportion of your muscle versus fat dependent on your stature and weight [40].

8.1.3 Take blood tests

Your medical care supplier will look at the degrees of androgens, cholesterol, and sugar in your blood [41].

8.1.4 Do a pelvic test or ultrasound to look at your ovaries

During the pelvic test, your medical care supplier will embed two fingers into your vagina and push on your midsection to feel for blisters on your ovaries. To assist with seeing growths in your ovaries, the individual in question may suggest an ultrasound, a test that utilizes sound waves to snap a photo of your pelvic region. Your medical care supplier likewise will check how thick the coating of your uterus is; if your periods are unpredictable, the covering of your uterus could be thicker than typical.


9. How is polycystic ovary syndrome treated?

Treatment for polycystic ovary syndrome depends on several aspects. These might incorporate your age, how serious your indications are, and your general well-being. The kind of treatment may likewise rely upon whether you need to become pregnant later on [42, 43].

  • If you do plan to become pregnant, your treatment may include:

A change in diet and activity

A sound eating routine and more active work can assist you with getting in shape and lessen your indications. They can likewise help your body to use insulin all the more productively, lower blood glucose levels, and may assist you with ovulating [44].

Medications to cause ovulation

Medicine can assist the ovaries with delivering eggs normally. These drugs additionally have specific dangers. They can expand the chances of multiple births (twins or more). What’s more, they can cause ovarian hyperstimulation. This is the point at which the ovaries discharge and excessive hormones. It can cause manifestations, for example, stomach bulging and pelvic agony [45].

  • If you do not plan to become pregnant, your treatment may include:

Birth control pills

These assist to control periods, lowering androgen levels, and diminishing skin inflammation [44].

Diabetes medication

This is frequently used to bring down insulin opposition in PCOS. It might likewise assist with diminishing androgen levels, slow hair development, and assist you with ovulating all the more routinely [46, 47].

A change in diet and activity

A healthy diet and more exercise can help you to reduce weight and your indication. They can also assist your body to utilize insulin more efficiently, diminish blood glucose levels, and may help in ovulating [48].

Medications to treat other symptoms

A few drugs can assist with lessening hair development or skin inflammation [47].


  1. 1. Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Reviews. 2016;37(5):467-520
  2. 2. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): Arguably the most common endocrinopathy is associated with significant morbidity in women. The Journal of Clinical Endocrinology & Metabolism. 1999;84(6):1897-1899
  3. 3. Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertility and Sterility. 2001;75(1):53-58
  4. 4. Group REASPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004;19(1):41-47
  5. 5. Sam S, Dunaif A. Polycystic ovary syndrome: Syndrome XX? Trends in Endocrinology & Metabolism. 2003;14(8):365-370
  6. 6. Khan MJ, Ullah A, Basit S. Genetic basis of polycystic ovary syndrome (PCOS): Current perspectives. The Application of Clinical Genetics. 2019;12:249
  7. 7. Carmina E, Napoli N, Longo R, Rini G, Lobo R. Metabolic syndrome in polycystic ovary syndrome (PCOS): Lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. European Journal of Endocrinology. 2006;154(1):141-145
  8. 8. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction. 2010;25(2):544-551
  9. 9. Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. International Journal of Environmental Research and Public Health. 2018;15(11):2589
  10. 10. Christensen SB, Black MH, Smith N, Martinez MM, Jacobsen SJ, Porter AH, et al. Prevalence of polycystic ovary syndrome in adolescents. Fertility and Sterility. 2013;100(2):470-477
  11. 11. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. The Lancet. 2007;370(9588):685-697
  12. 12. Franks S. Polycystic ovary syndrome. New England Journal of Medicine. 1995;333(13):853-861
  13. 13. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nature Reviews Endocrinology. 2011;7(4):219-231
  14. 14. Goudas VT, Dumesic DA. Polycystic ovary syndrome. Endocrinology and Metabolism Clinics of North America. 1997;26(4):893-912
  15. 15. Morgante G, Massaro M, Di Sabatino A, Cappelli V, De Leo V. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecological Endocrinology. 2018;34(1):4-9
  16. 16. Alchami A, O'Donovan O, Davies M. PCOS: Diagnosis and management of related infertility. Obstetrics, Gynaecology & Reproductive Medicine. 2015;25(10):279-282
  17. 17. Nestler JE. Metformin in the Treatment of Infertility in Polycystic Ovarian Syndrome: An Alternative Perspective. Elsevier; 2008
  18. 18. Thatcher SS, Jackson EM. Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertility and Sterility. 2006;85(4):1002-1009
  19. 19. Misso ML, Teede HJ, Hart R, Wong J, Rombauts L, Melder AM, et al. Status of clomiphene citrate and metformin for infertility in PCOS. Trends in Endocrinology & Metabolism. 2012;23(10):533-543
  20. 20. Leeman L, Acharya U. The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: The current evidence. Journal of Obstetrics and Gynaecology. 2009;29(6):467-472
  21. 21. Khan A, Karim N, Ainuddin JA. The triad of PCOS, infertility and metformin. Journal of Bahria University Medical and Dental College. 2019;9(1):67-71
  22. 22. Dumitrescu R, Mehedintu C, Briceag I, Purcărea V, Hudita D. Metformin-clinical pharmacology in PCOs. Journal of Medicine and Life. 2015;8(2):187
  23. 23. Batukan C, Baysal B. Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome. Archives of Gynecology and Obstetrics. 2001;265(3):124-127
  24. 24. Ota H, Goto T, Yoshioka T, Ohyama N. Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome. Fertility and Sterility. 2008;90(3):709-713
  25. 25. Palomba S, Falbo A, Orio F Jr, Tolino A, Zullo F. Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome. Fertility and Sterility. 2009;91(6):2557-2567
  26. 26. Wang F, Dai W, Yang X-H, Guo Y-H, Sun Y-P. Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China. Scientific Reports. 2016;6(1):1-9
  27. 27. Palomba S, Oppedisano R, Tolino A, Orio F, Zullo F. Metformin use in infertile patients with polycystic ovary syndrome: An evidence-based overview. Reproductive Biomedicine Online. 2008;16(3):327-335
  28. 28. Davis SR, Knight S, White V, Claridge C, Davis BJ, Bell R. Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women. Gynecological Endocrinology. 2002;16(6):443-446
  29. 29. Bozdag G, Yildiz BO. Combined oral contraceptives in polycystic ovary syndrome–indications and cautions. Polycystic Ovary Syndrome. 2013;40:115-127
  30. 30. Vause TD, Cheung AP, Sierra S, Claman P, Graham J, Guillemin J-A, et al. Ovulation induction in polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Canada. 2010;32(5):495-502
  31. 31. Vitek W, Alur S, Hoeger KM. Off-label drug use in the treatment of polycystic ovary syndrome. Fertility and Sterility. 2015;103(3):605-611
  32. 32. Stankiewicz M, Norman R. Diagnosis and management of polycystic ovary syndrome. Drugs. 2006;66(7):903-912
  33. 33. Muth S, Norman J, Sattar N, Fleming R. Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: Indications for a change in licensing arrangements? Human Reproduction. 2004;19(12):2718-2720
  34. 34. Kalra B, Kalra S, Sharma J. The inositols and polycystic ovary syndrome. Indian Journal of Endocrinology and Metabolism. 2016;20(5):720
  35. 35. Holton S, Hammarberg K, Johnson L. Fertility concerns and related information needs and preferences of women with PCOS. Human Reproduction Open. 2018;2018(4):hoy019
  36. 36. Barbosa G, de Sá LBPC, Rocha DRTW, Arbex AK. Polycystic ovary syndrome (PCOS) and fertility. Open Journal of Endocrine and Metabolic Diseases. 2016;6(1):58-65
  37. 37. Moffett RC, Naughton V. Emerging role of GIP and related gut hormones in fertility and PCOS. Peptides. 2020;125:170233
  38. 38. Elshewy N, Ji D, Zhang Z, Chen D, Chen B, Xue R, et al. Association between mild stimulated IVF/M cycle and early embryo arrest in sub fertile women with/without PCOS. Reproductive Biology and Endocrinology. 2020;18(1):1-11
  39. 39. Haas J, Bentov Y. Should metformin be included in fertility treatment of PCOS patients? Medical Hypotheses. 2017;100:54-58
  40. 40. Lentscher JA, Slocum B, Torrealday S. Polycystic ovarian syndrome and fertility. Clinical Obstetrics and Gynecology. 2021;64(1):65-75
  41. 41. Valdimarsdottir R, Wikström A-K, Kallak TK, Elenis E, Axelsson O, Preissl H, et al. Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels. Reproductive BioMedicine Online. 2021;42(1):217-225
  42. 42. Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: Systematic review and meta-analysis. BMJ. 2003;327(7421):951
  43. 43. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Human Reproduction. 2016;31(12):2841-2855
  44. 44. Lim S, Norman RJ, Davies M, Moran L. The effect of obesity on polycystic ovary syndrome: A systematic review and meta-analysis. Obesity Reviews. 2013;14(2):95-109
  45. 45. Lim S, Kakoly N, Tan J, Fitzgerald G, Bahri Khomami M, Joham A, et al. Metabolic syndrome in polycystic ovary syndrome: A systematic review, meta-analysis and meta-regression. Obesity Reviews. 2019;20(2):339-352
  46. 46. Creanga AA, Bradley HM, McCormick C, Witkop CT. Use of metformin in polycystic ovary syndrome: A meta-analysis. Obstetrics & Gynecology. 2008;111(4):959-968
  47. 47. Skiba MA, Islam RM, Bell RJ, Davis SR. Understanding variation in prevalence estimates of polycystic ovary syndrome: A systematic review and meta-analysis. Human Reproduction Update. 2018;24(6):694-709
  48. 48. Boomsma C, Eijkemans M, Hughes E, Visser G, Fauser B, Macklon N. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Human Reproduction Update. 2006;12(6):673-683

Written By

Naheed Akhter, Sadia Sana, Naila Iftikhar, Muhammad Adnan Ahsan, Abu Huraira and Zafaar Siddique

Submitted: 15 November 2021 Reviewed: 07 December 2021 Published: 21 March 2022